| Primary |
| Product Used For Unknown Indication |
27.2% |
| Retinal Vein Occlusion |
23.8% |
| Macular Oedema |
17.1% |
| Uveitis |
7.1% |
| Cystoid Macular Oedema |
5.5% |
| Drug Use For Unknown Indication |
3.5% |
| Hypertension |
2.0% |
| Central Retinal Vein Occlusion |
1.8% |
| Diabetes Mellitus |
1.6% |
| Intermediate Uveitis |
1.4% |
| Prophylaxis |
1.4% |
| Depression |
1.2% |
| Glaucoma |
1.0% |
| Choroiditis |
0.8% |
| Diabetic Retinal Oedema |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Macular Edema |
0.8% |
| Thrombosis |
0.8% |
| Arthralgia |
0.6% |
| Chorioretinitis |
0.6% |
|
| Endophthalmitis |
22.6% |
| Device Dislocation |
14.6% |
| Visual Acuity Reduced |
8.8% |
| Intraocular Pressure Increased |
7.3% |
| Vitreous Haemorrhage |
6.9% |
| Complication Of Device Insertion |
5.5% |
| Corneal Oedema |
5.5% |
| Retinal Detachment |
5.5% |
| Ocular Hypertension |
3.3% |
| Hypotony Of Eye |
2.6% |
| Visual Impairment |
2.6% |
| Eye Pain |
2.2% |
| Glaucoma |
2.2% |
| Retinal Tear |
1.8% |
| Blindness |
1.5% |
| Conjunctival Haemorrhage |
1.5% |
| Corneal Decompensation |
1.5% |
| Drug Ineffective |
1.5% |
| Intraocular Pressure Decreased |
1.5% |
| Macular Hole |
1.5% |
|
| Secondary |
| Product Used For Unknown Indication |
27.8% |
| Retinal Vein Occlusion |
19.4% |
| Macular Oedema |
15.0% |
| Cystoid Macular Oedema |
7.2% |
| Uveitis |
5.6% |
| Hiv Infection |
3.3% |
| Macular Edema |
3.3% |
| Central Retinal Vein Occlusion |
2.8% |
| Intermediate Uveitis |
2.2% |
| Blood Cholesterol Increased |
1.7% |
| Choroiditis |
1.7% |
| Prophylaxis |
1.7% |
| Scleritis |
1.7% |
| Urinary Retention |
1.7% |
| Diabetic Retinal Oedema |
1.1% |
| Oedema |
1.1% |
| Retinal Oedema |
1.1% |
| Antibiotic Prophylaxis |
0.6% |
| Chorioretinitis |
0.6% |
| Glaucoma |
0.6% |
|
| Endophthalmitis |
17.9% |
| Eye Pain |
11.9% |
| Vitreous Haemorrhage |
11.9% |
| Device Dislocation |
7.5% |
| Hypopyon |
7.5% |
| Retinal Detachment |
6.0% |
| Visual Acuity Reduced |
6.0% |
| Vitreous Floaters |
6.0% |
| Complication Of Device Insertion |
4.5% |
| Intraocular Pressure Increased |
3.0% |
| Pneumonia |
3.0% |
| Visual Impairment |
3.0% |
| Blindness |
1.5% |
| Corneal Oedema |
1.5% |
| Device Colour Issue |
1.5% |
| Eye Infection Toxoplasmal |
1.5% |
| Glaucoma |
1.5% |
| Hypotony Of Eye |
1.5% |
| Retinal Tear |
1.5% |
| Sudden Visual Loss |
1.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
100.0% |
|
| Visual Acuity Reduced |
100.0% |
|
